Find a clinic
Questions about treatments
Questions about our technologies or workstations
General inquiries email
WHAT IS MORPHEUS8?
Morpheus8 is a minimally invasive epidermal resurfacing and Subdermal Adipose Remodeling Device (SARD). It delivers clinically proven fractional bipolar radiofrequency through a matrix of microneedles for subdermal adipose tissue remodeling, dermal remodeling, and epidermal resurfacing.
KEY BENEFITS:
- For facial soft tissue and small treatment areas.
- Clinically proven to remodel subdermal and dermal tissue through bulk sub-necrotic heating and fractional coagulation of fat.
- Three interchangeable fractional tips with different microneedling configurations:
- 12 pin Morpheus8 Prime for small narrow areas such as the periorbital zone and upper lip
- 24 pin Morpheus8 for larger areas such as the forehead, nasolabial folds, jawlines, and neck
- 24 pin Morpheus8 Resurfacing for the treatment of superficial conditions, including scarring
- Safe on skin types I to VI with little risk of post inflammatory hyperpigmentation (PIH) which is common with other resurfacing methods.
INDICATIONS FOR USE IN EUROPE:
- Provides a reduction in acne lesions and improvement in acne scars and skin appearance.
- Little to no thermal damage to the skin surface, including transient erythema, transient edema, transient crusting, tolerable discomfort, tolerable pain, and reversible change of pigmentation.
Morpheus8 Video
RENEW FACIAL TISSUE
Morpheus8 targets subdermal layers to remodel collagen and enhance the appearance of the tissue.
STIMULATE COLLAGEN
Stimulate the production of collagen in the underlying layers of the dermis. The Morpheus8 modular tips enable procedures to be customized to treat small facial zones.
DARKER SKIN TONES
Morpheus8 effectively remodels skin and tissue with minimal risk of post-inflammatory hyperpigmentation. Patients should expect little to no thermal damage to skin types I – VI.
Approved intended use varies by country; please check with local providers or representatives. Individual treatment results may vary.
Clinical and peer-reviewed publications are published by a third party and based on physician experiences and study results. InMode does not take responsibility for or endorse the content provided by the independent practitioners as the language may differ than InMode manufacturer clearances.